Concepedia

Catharina Bäärnhielm

CB

11

Publications

382

Citations

11

H-Index

1984

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Catharina Bäärnhielm is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and biochemistry.

Top concepts

Publications per year

1984–2003

11

Publications

11

<i>In Vivo</i>Pharmacokinetics of Felodipine Predicted from<i>in Vitro</i>Studies in Rat, Dog and Man

Catharina Bäärnhielm, Helena Dahlbäck, Inger Skånberg · Acta Pharmacologica et Toxicologica · 1986 · 98 citations

Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant

Christoffer Abrahamsson, M Dean Palmer, Bengt Ljung et al. · Cardiovascular Research · 1994 · 67 citations

Cytochrome P-450-dependent oxidation of felodipine—a 1,4-dihydropyridine—to the corresponding pyridine

Catharina Bäärnhielm, Inger Skånberg, K. O. Borg · Xenobiotica · 1984 · 48 citations

Oxidation of 1,4-dihydropyridines by prostaglandin synthase and the peroxidic function of cytochrome P-450

Catharina Bäärnhielm, Göran K. Hansson · Biochemical Pharmacology · 1986 · 28 citations

, , +12

Stereoselective metabolism of felodipine in liver microsomes from rat, dog, and human.

Ulf G. Eriksson, Jonas Lundahl, Catharina Bäärnhielm et al. · Drug Metabolism and Disposition · 1991 · 25 citations

Rows per page

1–5 of 11